Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 27 (6 Suppl 3), III7-11

Assessing Coronary Heart Disease Risk With Traditional and Novel Risk Factors

Affiliations
Review

Assessing Coronary Heart Disease Risk With Traditional and Novel Risk Factors

Peter W F Wilson. Clin Cardiol.

Abstract

Cardiovascular disease is the leading cause of death in the industrialized world, and a number of well-characterized factors, including advanced age, hypertension, dyslipidemia, diabetes, and smoking, contribute to cardiovascular risk. Integration of these factors using the Framingham calculation estimates the absolute 10-year risk for coronary heart disease (CHD), which can be used to guide therapy. Recent studies have demonstrated that additional markers, including elevated lipoprotein(a), homocysteine, sitosterol, and particularly C-reactive protein (CRP), are also associated with increased risk for CHD. In particular, high-sensitivity CRP has been shown to identify patients with high CHD risk who may not have elevated low-density lipoprotein cholesterol (LDL-C) and may add to the predictive value of the Framingham functions for CHD risk assessment. Assessment of global risk is particularly important in lipid management, as the LDL-C target goals are determined by risk category.

Similar articles

See all similar articles

Cited by 10 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources

Feedback